• English
  • Korean
  • Chinese
市場調査レポート - 245624

中国における体外診断試薬産業の分析

Research Report on Global and China In-vitro Diagnostic Reagent Industry, 2013-2017

発行 China Research and Intelligence
出版日 ページ情報 英文 50 Pages
価格
中国における体外診断試薬産業の分析 Research Report on Global and China In-vitro Diagnostic Reagent Industry, 2013-2017
出版日: 2013年08月01日 ページ情報: 英文 50 Pages
概要

中国の体外診断市場における参入障壁は高くなく、集中率は低くなっています。一方、現在の産業規模や発達水準はまだ低いですが、今後は急速に成長するものと思われます。2012年における中国市場の規模は136億人民元に達し、その大半を免疫診断試薬や生化学診断試薬、分子診断試薬などが占めています。

当レポートでは、中国の体外診断試薬における最新動向について分析し、全体的な産業構造や発展環境、全般的な供給・需要構造、市場の競合情勢、主要企業の最新動向、政策環境、および今後の発展予測などを調査しており、概略以下の構成でお届けします。

第1章 体外診断試薬産業の概要

  • 定義
  • 分類
    • 診断原理・診断手法別の分類
    • 中国独自の分類方法
  • 対外診断試薬の関連産業

第2章 世界の体外診断試薬産業

  • 概要
    • 開発方針
    • 競合パターン
    • 市場規模
  • 世界の主要メーカー
    • F. Hoffmann-La Roche, Ltd.
    • Siemens AG
    • Abbott Laboratories

第3章 中国の体外診断試薬産業の発展環境

  • 経済環境
  • 政策環境
    • 監督機関
    • 企業設立に関する政策
    • 製造に関する政策
    • 流通に関する政策

第4章 中国の体外診断試薬産業の操業状況(過去5年間分)

  • 発展過程
  • 参入障壁
    • 政策障壁
    • 技術障壁
    • チャネル障壁
  • 供給状況
    • 主要メーカー
    • 市場供給量
    • 競争状態
    • 製品輸出入の状況
  • 中国国内の市場需要
    • 全体的な市場規模
    • 生化学診断試薬の市場規模
    • 免疫診断試薬の市場規模
    • 分子診断試薬の市場規模

第5章 中国の体外診断試薬産業の上位企業5社

  • Shanghai Kehua Bio-engineering Co., Ltd.
  • Shanghai Fosun Pharmaceutical Co., Ltd.
  • DAAN Gene Co., Ltd. of Sun Yat-sen University
  • Beijing Leadman Biochemistry Co., Ltd.
  • BioSino Bio-technology and Science Inc.

第6章 中国の体外診断試薬産業の将来展望(今後5年間分)

  • 供給量の予測
  • 市場需要の予測
    • 産業の発展動向
    • 全体的な市場規模の予測
    • 分野別の市場規模の予測
  • 市場競合についての予測
    • 注目製品の予測
    • 競合パターンの予測

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

In Chinese market, there are mainly three categories of in-vitro diagnostic reagents, biochemical diagnostic reagents, immune diagnostic reagents and molecular diagnostic reagents, accounting for about 65% of in-vitro diagnostic reagent market in total in 2012.

Global in-vitro diagnostics market is mature and the concentration rate is high. The 8 major enterprises account for over 70% market share. In 2011, the market scale of global in-vitro diagnostics reached USD 46 billion, among which developed countries accounted for over 80%. Currently, emerging economic entities occupy low proportions, while their growth rates are far ahead of that of mature markets.

In China, barriers to entry of this industry are not high and the concentration rate is low. The majority of enterprises concentrate in the biochemical reagent field, so the competition is mainly in the biochemical field. Both the supply and demand of immune and molecular products are prosperous. In addition to immune reagents, markets of other diagnostic reagents are mainly occupied by Chinese domestic enterprises. Although China in-vitro diagnostic reagent industry started late and its scale is limited, it grows rapidly. In 2012, the market scale reached CNY 13.6 billion, among which immune diagnostic reagents, biochemical diagnostic reagents and molecular diagnostic reagents ranked among the top.

According to the investigation of CRI, the production line utilization of various in-vitro diagnostic reagent manufacturers is universally high. Therefore, CRI predicts that the production capacity of the industry will expand in the future. Furthermore, the development strategy of most enterprises is transversely enriching product varieties and vertically developing towards the upstream and downstream.

China's population accounts for more than 20% of the world's population, while the market share of in-vitro diagnostics is less than 5% of the world's; in 2012, the annual consumption per capita of China's in-vitro diagnostic products was less than USD 2, while that of developed countries reached USD 25 to USD 30. Therefore, there is a wide growth space for China's in-vitro diagnostics. CRI predicts that the growth rate of the market scale of China's in-vitro diagnostics will be markedly higher than the global average level and the CAGR will maintain over 15% from 2013 to 2017. By 2017, the market scale will reach CNY 30 billion, among which immune and biochemical products will continually occupy most of the market share, while the proportion of molecular products will relatively increase. During the upgrading of products in the future and the process of domestic substitution, the industry concentration rate will grow.

Before 2003, medium and high-end diagnostic products were monopolized by imports, but the improvement of domestic diagnostic reagent production levels has significantly changed the market pattern. In the primary market, the share of domestically made reagents is increasing gradually, while foreign enterprises still dominate the instrument market. Currently, Chinese domestic enterprises are gradually expanding from reagents to instruments and occupying the market through advantages of instruments to promote the sales of reagents. As diagnostic services are charged by project, medical institutions prefer cheaper domestically produced reagents as long as the quality is ensured. The costs saved can directly become revenue of the institutions. Currently, biochemical and enzyme immunoassay diagnostics continue to dominate the market of diagnostic reagents.

Readers can obtain the following information or more through this report:

  • Status of Global and China In-vitro Diagnostic Reagents
  • Governmental Policies on China In-vitro Diagnostic Reagent Industry
  • Status of Market Competition in In-vitro Diagnostic Reagent Industry
  • Major In-vitro Diagnostic Reagent Manufacturers in Global and China Markets
  • Forecast on the Development of In-vitro Diagnostic Reagent Industry

The Following Enterprises and People Are Recommended to Purchase This Report:

  • In-vitro Diagnostic Reagent Manufacturers
  • In-vitro Diagnostic Reagent Trading Enterprises
  • Medical Institutions
  • Research Institutions/Investors Concerned About In-vitro Diagnostic Reagent Industry

Table of Contents

Chapter 1 - Overview on In-vitro Diagnostic Reagent Industry

  • 1.1. Definition
  • 1.2. Classification
    • 1.2.1. Classification by Diagnosis Principles or Diagnosis Methods
    • 1.2.2. China-featured Classification Methods
  • 1.3. Industry Chain of In-vitro Diagnostic Reagents

Chapter 2 - Global In-vitro Diagnostic Reagent Industry, 2011-2013

  • 2.1. Industry Overview
    • 2.1.1. Development Process
    • 2.1.2. Competition Pattern
    • 2.1.3. Market Scale
  • 2.2. Major Manufacturers of Global In-vitro Diagnostic Reagent Industry
    • 2.2.1. F. Hoffmann-La Roche, Ltd.
    • 2.2.2. Siemens AG
    • 2.2.3. Abbott Laboratories

Chapter 3 - Development Environment of China In-vitro Diagnostic Reagent Industry, 2011-2013

  • 3.1. Economic Environment
  • 3.2. Policy Environment
    • 3.2.1. Competent Government Authorities
    • 3.2.2. Policies on Enterprise Establishment
    • 3.2.3. Policies on Production
    • 3.2.4. Policies on Circulation

Chapter 4 - Operation Status of China Diagnostic Reagent Industry, 2008-2012

  • 4.1. Development Process of China In-vitro Diagnostic Reagent Industry16
  • 4.2. Barriers to Entry
    • 4.2.1. Policy Barriers
    • 4.2.2. Technological Barriers
    • 4.2.3. Sales Channel Barriers
  • 4.3. Supply Status of China In-vitro Diagnostic Reagent Industry
    • 4.3.1. Major Manufacturers
    • 4.3.2. Market Supply
    • 4.3.3. Status of Market Competition
    • 4.3.4. Status of Product Import and Export
  • 4.4. Market Demand for In-vitro Diagnostic Reagents in China
    • 4.4.1. Overall Market Scale
    • 4.4.2. Market Scale of Biochemical Diagnostic Reagents
    • 4.4.3. Market Scale of Immune Diagnostic Reagents
    • 4.4.4. Market Scale of Molecular Diagnostic Reagents

Chapter 5 - Top 5 Enterprises of China's In-vitro Diagnostic Reagent Industry, 2011-2013

  • 5.1. Shanghai Kehua Bio-engineering Co., Ltd.
  • 5.2. Shanghai Fosun Pharmaceutical Co., Ltd.
  • 5.3. DAAN Gene Co., Ltd. of Sun Yat-sen University
  • 5.4. Beijing Leadman Biochemistry Co., Ltd.
  • 5.5. BioSino Bio-technology and Science Inc.

Chapter 6 - Prospect of China In-vitro Diagnostic Reagent Industry, 2013-2017

  • 6.1. Forecast on Supply
  • 6.2. Forecast on Market Demand
    • 6.2.1. Industry Development Trend
    • 6.2.2. Forecast on Overall Market Scale
    • 6.2.3. Forecast on Segmented Market Scale
  • 6.3. Forecast on Market Competition
    • 6.3.1. Forecast on Popular Products
    • 6.3.2. Forecast on Competition Pattern

Selected Charts

  • Chart Sales Value of Global Major In-vitro Diagnostics Enterprises, 2012
  • Chart Market Scale of Global In-vitro Diagnostics Industry, 2007-2012
  • Chart Market Distribution of Global In-vitro Diagnostics Industry, 2012
  • Chart Forecast on Market Scale of China In-vitro Diagnostic Reagents Industry, 2013-2017
  • Chart Sales Value of In-vitro Diagnostics Products of Roche Diagnostics Department, 2008-2012
  • Chart Major In-vitro Diagnostic Reagent Products of Roche on China Market
  • Chart Sales Value of In-vitro Diagnostics Products of Siemens Diagnostic Business Group, 2008-2012
  • Chart Sales Value of In-vitro Diagnostics Products of Abbott Diagnostics Department, 2008-2012
  • Chart Major Laws and Regulations on China's In-vitro Diagnostic Reagent Industry
  • Chart Major Manufacturers of In-vitro Diagnostic Reagents in China
  • Chart Market Scale of China In-vitro Diagnostic Reagents, 2007-2012
  • Chart Market Segmentation of China In-vitro Diagnostic Reagents, 2012
  • Chart Market Scale of China Biochemical In-vitro Diagnostic Reagents, 2007-2012
  • Chart Market Scale of China Immune In-vitro Diagnostic Reagents, 2007-2012
  • Chart Market Scale of China Molecular In-vitro Diagnostic Reagents, 2007-2012
  • Chart Major In-vitro Diagnostic Reagent Products of Shanghai Kehua Bio-engineering Co., Ltd.
  • Chart Sales Value of Diagnostic Reagent Products of Shanghai Kehua Bio-engineering Co., Ltd., 2008-2012
  • Chart Diagnostic Reagent Product Structure of Shanghai Kehua Bio-engineering Co., Ltd., 2012-2013
  • Chart Major In-vitro Diagnostic Reagent Products of Beijing Leadman Biochemistry Co., Ltd.
  • Chart Sales Value of Diagnostic Reagent Products of Beijing Leadman Biochemistry Co., Ltd., 2008-2012
  • Chart Forecast on Market Scale of China In-vitro Diagnostic Reagents, 2013-2017
  • Chart Forecast on Market Scale of China Biochemical In-vitro Diagnostic Reagents, 2013-2017
  • Chart Forecast on Market Scale of China Immune In-vitro Diagnostic Reagents, 2013-2017
Back to Top